<VariationArchive RecordType="classified" VariationID="689749" VariationName="NM_001367721.1(CASK):c.913_914dup (p.Gly306fs)" VariationType="Duplication" Accession="VCV000689749" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2019-09-21" MostRecentSubmission="2019-09-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="677470" VariationID="689749">
      <GeneList>
        <Gene Symbol="CASK" FullName="calcium/calmodulin dependent serine protein kinase" GeneID="8573" HGNC_ID="HGNC:1497" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="41514934" stop="41923554" display_start="41514934" display_stop="41923554" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="41374186" stop="41782286" display_start="41374186" display_stop="41782286" Strand="-" />
          </Location>
          <OMIM>300172</OMIM>
          <Haploinsufficiency last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CASK">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CASK">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001367721.1(CASK):c.913_914dup (p.Gly306fs)</Name>
      <CanonicalSPDI>NC_000023.11:41636578:TTT:TTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="41636578" stop="41636579" display_start="41636578" display_stop="41636579" variantLength="2" positionVCF="41636578" referenceAlleleVCF="C" alternateAlleleVCF="CTT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="41495831" stop="41495832" display_start="41495831" display_stop="41495832" variantLength="2" positionVCF="41495831" referenceAlleleVCF="C" alternateAlleleVCF="CTT" />
      </Location>
      <ProteinChange>G306fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.41495833_41495834dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.41495833_41495834dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.41636580_41636581dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.41636580_41636581dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016754.2" sequenceAccession="NG_016754" sequenceVersion="2" change="g.291455_291456dup">
            <Expression>NG_016754.2:g.291455_291456dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126054.3" sequenceAccession="NM_001126054" sequenceVersion="3" change="c.912_913dup">
            <Expression>NM_001126054.3:c.912_913dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119526.1" sequenceAccession="NP_001119526" sequenceVersion="1" change="p.Gly306Argfs">
            <Expression>NP_001119526.1:p.Gly306Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126055.3" sequenceAccession="NM_001126055" sequenceVersion="3" change="c.912_913dup">
            <Expression>NM_001126055.3:c.912_913dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119527.1" sequenceAccession="NP_001119527" sequenceVersion="1" change="p.Gly306Argfs">
            <Expression>NP_001119527.1:p.Gly306Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001367721.1" sequenceAccession="NM_001367721" sequenceVersion="1" change="c.913_914dup" MANESelect="true">
            <Expression>NM_001367721.1:c.913_914dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354650.1" sequenceAccession="NP_001354650" sequenceVersion="1" change="p.Gly306fs">
            <Expression>NP_001354650.1:p.Gly306fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410745.1" sequenceAccession="NM_001410745" sequenceVersion="1" change="c.912_913dup">
            <Expression>NM_001410745.1:c.912_913dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397674.1" sequenceAccession="NP_001397674" sequenceVersion="1" change="p.Gly306Argfs">
            <Expression>NP_001397674.1:p.Gly306Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003688.4" sequenceAccession="NM_003688" sequenceVersion="4" change="c.912_913dup">
            <Expression>NM_003688.4:c.912_913dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003679.2" sequenceAccession="NP_003679" sequenceVersion="2" change="p.Gly306Argfs">
            <Expression>NP_003679.2:p.Gly306Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1602386709" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001367721.1(CASK):c.913_914dup (p.Gly306fs) AND multiple conditions" Accession="RCV000850537" Version="3">
        <ClassifiedConditionList TraitSetID="8833">
          <ClassifiedCondition DB="MedGen" ID="C1845546">FG syndrome 4</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2677903">Syndromic X-linked intellectual disability Najm type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-12-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-09-21" MostRecentSubmission="2019-09-21">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8833" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5151" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">FG syndrome 4</ElementValue>
                <XRef ID="FG+Syndrome+4/2845" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010318" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-Linked Intellectual Disability with or without Nystagmus</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CASK</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">FGS4</ElementValue>
                <XRef Type="MIM" ID="300422" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9925" />
                <XRef ID="9925" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CASK disorders include a spectrum of phenotypes in both females and males. Two main types of clinical presentation are seen: Microcephaly with pontine and cerebellar hypoplasia (MICPCH), generally associated with pathogenic loss-of-function variants in CASK. X-linked intellectual disability (XLID) with or without nystagmus, generally associated with hypomorphic CASK pathogenic variants. MICPCH is typically seen in females with moderate-to-severe intellectual disability, progressive microcephaly with or without ophthalmologic anomalies, and sensorineural hearing loss. Most are able to sit independently; 20%-25% attain the ability to walk; language is nearly absent in most. Neurologic features may include axial hypotonia, hypertonia/spasticity of the extremities, and dystonia or other movement disorders. Nearly 40% have seizures by age ten years. Behaviors may include sleep disturbances, hand stereotypies, and self biting. MICPCH in males may occur with or without severe epileptic encephalopathy in addition to severe-to-profound developmental delay. When seizures are present they occur early and may be intractable. In individuals and families with milder (i.e., hypomorphic) pathogenic variants, the clinical phenotype is usually that of XLID with or without nystagmus and additional clinical features. Males have mild-to-severe intellectual disability, with or without nystagmus and other ocular features. Females typically have normal intelligence with some displaying mild-to-severe intellectual disability with or without ocular features.</Attribute>
                <XRef ID="NBK169825" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24278995</ID>
                <ID Source="BookShelf">NBK169825</ID>
              </Citation>
              <XRef ID="C1845546" DB="MedGen" />
              <XRef ID="MONDO:0010318" DB="MONDO" />
              <XRef Type="MIM" ID="300422" DB="OMIM" />
            </Trait>
            <Trait ID="2748" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mental retardation and microcephaly with pontine and cerebellar hypoplasia</ElementValue>
                <XRef ID="Mental+retardation+and+microcephaly+with+pontine+and+cerebellar+hypoplasia/8814" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MICPCH SYNDROME</ElementValue>
                <XRef Type="MIM" ID="300749" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Syndromic X-linked intellectual disability Najm type</ElementValue>
                <XRef ID="MONDO:0010417" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND PONTINE AND CEREBELLAR HYPOPLASIA</ElementValue>
                <XRef Type="MIM" ID="300749" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300172.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300172.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300172.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300172.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300172.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300172.0012" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED, SYNDROMIC, NAJM TYPE</ElementValue>
                <XRef Type="MIM" ID="300749" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Intellectual Disability and Microcephaly with Pontine and Cerebellar Hypoplasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MICPCH</ElementValue>
                <XRef Type="MIM" ID="300749" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CASK disorders include a spectrum of phenotypes in both females and males. Two main types of clinical presentation are seen: Microcephaly with pontine and cerebellar hypoplasia (MICPCH), generally associated with pathogenic loss-of-function variants in CASK. X-linked intellectual disability (XLID) with or without nystagmus, generally associated with hypomorphic CASK pathogenic variants. MICPCH is typically seen in females with moderate-to-severe intellectual disability, progressive microcephaly with or without ophthalmologic anomalies, and sensorineural hearing loss. Most are able to sit independently; 20%-25% attain the ability to walk; language is nearly absent in most. Neurologic features may include axial hypotonia, hypertonia/spasticity of the extremities, and dystonia or other movement disorders. Nearly 40% have seizures by age ten years. Behaviors may include sleep disturbances, hand stereotypies, and self biting. MICPCH in males may occur with or without severe epileptic encephalopathy in addition to severe-to-profound developmental delay. When seizures are present they occur early and may be intractable. In individuals and families with milder (i.e., hypomorphic) pathogenic variants, the clinical phenotype is usually that of XLID with or without nystagmus and additional clinical features. Males have mild-to-severe intellectual disability, with or without nystagmus and other ocular features. Females typically have normal intelligence with some displaying mild-to-severe intellectual disability with or without ocular features.</Attribute>
                <XRef ID="NBK169825" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12669" />
                <XRef ID="12669" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24278995</ID>
                <ID Source="BookShelf">NBK169825</ID>
              </Citation>
              <XRef ID="163937" DB="Orphanet" />
              <XRef ID="C2677903" DB="MedGen" />
              <XRef ID="MONDO:0010417" DB="MONDO" />
              <XRef Type="MIM" ID="300749" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1946388" SubmissionDate="2019-03-14" DateLastUpdated="2019-09-21" DateCreated="2019-09-21">
        <ClinVarSubmissionID localKey="NC_000023.10:g.41495833_41495834dupTT|OMIM:300422;300749" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000992746" DateUpdated="2019-09-21" DateCreated="2019-09-21" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CASK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.41495833_41495834dupTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300422" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300749" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5321481</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1946388" TraitType="Disease" MappingType="XRef" MappingValue="300749" MappingRef="OMIM">
        <MedGen CUI="C2677903" Name="Syndromic X-linked intellectual disability Najm type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1946388" TraitType="Disease" MappingType="XRef" MappingValue="300422" MappingRef="OMIM">
        <MedGen CUI="C1845546" Name="FG syndrome 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

